About
Blindness Treatment Gene Therapy and Device
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyUncategorized Medical DeviceNJ, NY, PA
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
7
As Collaborator
2
Total Enrollment
351
By Phase
PHASE1/PHASE2: 3PHASE3: 1NA: 4
By Status
COMPLETED: 4NOT_YET_RECRUITING: 1RECRUITING: 1WITHDRAWN: 1TERMINATED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT07158775Lead Sponsor
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD
PHASE1/PHASE2Not yet recruiting
40 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2031
NCT07195721Lead Sponsor
The Effect of PROSE Treatment on Mental Health
N/ARecruiting
200 participants
Started: Nov 11, 2024 · Completed: Oct 31, 2029
NCT04918823Lead Sponsor
Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE Device
PHASE1/PHASE2Completed
10 participants
Started: Jul 15, 2021 · Completed: Apr 14, 2023
NCT04735510Lead Sponsor
Novel Use of Restasis and PROSE Devices
PHASE3Withdrawn
Started: May 31, 2021 · Completed: Sep 30, 2021
NCT04649177Lead Sponsor
Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting
NACompleted
11 participants
Started: Dec 15, 2020 · Completed: Mar 23, 2022
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...